2,4-DINITROPHENYL RECEPTORS ON MOUSE THYMUS AND SPLEEN CELLS by Lawrence, David A. et al.
2,4-DINITROPHENYL RECEPTORS  ON  MOUSE  THYMUS 
AND  SPLEEN  CELLS* 
B~' DAVID  A.  LAWRENCE,~  HANS L.  SPIEGELBERG, 
ANn WILLIAM  O.  WEIGLE§ 
(From the Department of Experimental Pathology, Scripps Clinic and Research 
Foundation, La Jolla, California  92037) 
(Received for publication 22 September 1972) 
It has been demonstrated that bone marrow-derived lymphoid cells, or B cells, 1  and 
thymus-derived lymphoid cells,  or T  cells,  have antigen-specific receptors on their 
plasma membranes. Direct evidence for this has been provided for the B cell popula- 
tion with techniques such as autoradiography (1-3) and immunoadsorbent depletion 
of specific lymphoid cells  (4,  5),  whereas it has been more difficult to obtain direct 
evidence that T  cells bind antigen. Most of the data on antigen-binding  cells in the 
thymus have been obtained by indirect methods such as antigen suicide (6)  and in- 
hibition of  T  cell  functions by anti-immunoglobulin sera  (7-9).  In recent studies, 
however, antigen-binding T  cells have been detected  by a  rosette formation assay 
(10),  enzymatic methods  (11, 12), and autoradiography (13).  Since  it does  appear 
that  the specific receptors  are most likely immunoglobulin in nature, it is not sur- 
prising that  immunoglobulins have been easily detected  on the  surfaces of  B  cells 
(14-16),  whereas  their presence on T  cells has  been more difficult to  demonstrate 
(17, 18). 
In order to further characterize antigen-specific receptors, especially those on 
T  cells,  the  present  investigation was  undertaken to  study  the  2,4-dinitro- 
phenyl (DNP)  receptors  on spleen and thymus cells. These specific receptors 
were investigated because of some interesting aspects of the immune response 
to DNP which include (a)  the presence of agglutinating anti-DNP antibodies 
in the  sera  of nonimmunized humans (19);  (b)  the  existence of  a  number of 
myeloma proteins of mice and man with anti-DNP activity (20); and (c)  the 
occurrence of a large number of antibody-forming cells to DNP in normal and 
* Publication no. 639 from the Department of Experimental Pathology, Scripps Clinic and 
Research Foundation, La Jolla, Calif. The work was supported in part by grants AI-07007 and 
AI-10734-01 from the National Institutes of Health, American Heart Association Grant-in-Aid 
70710, National Science  Foundation GB-25763, and American Cancer Society 'F .519. 
:~ Supported by U. S. Public Health Service Training Grant 5T1 GM683. 
§ Supported by U. S. Public Health Service Research Career Award 5-K6-GM-6936. 
l Abbreviations used in this paper: B cells, bone marrow-derived cells; BSS, balanced salt 
solution; DNP, 2,4-dinitrophenyl;  FCS, fetal calf serum; HEPES,  N-2-hydroxyethylpipera- 
zine-N'-2-ethanesulfonic acid;  HGG, human IgG;  MEM,  minimum essential medium; m- 
NBDF,  meta-nitrobenzenediazonium  fluoborate;  p-NBDF,  para-nitrobenzenediazonium 
fluoborate; OA, oval  bumin ; T cells, thymus-derived cells. 
470  THE  JOURNAL OF  EXPERIMENTAL MEDICINE • VOLUME 137,  1973 LAWRENCE,  SPIEGELBERG~  AND  WEIGLE  471 
immunized animals (21,  22).  It could,  therefore, be expected that a  large num- 
ber of lymphoid cells with DNP  receptors may be detectable. Autoradiography 
has been employed to quantitate  the antigen-binding lymphocytes in thymuses 
and  spleens  of  normal  CBA/J  mice  and  to  examine  the characteristics  of  the 
receptors  with  antisera  specific for  immunoglobulin  chains  and  fragments.  In 
these  studies  we  have  detected  qualitative  differences  between  thymic  and 
splenic DNP-binding  receptors. 
Materials and Methods 
Thymus and Spleen Cell Preparation.--The  thymus and spleen cells were obtained from nor- 
mal 5-7-wk-old CBA/J mice (Jackson Laboratory, Bar Harbor, Me.). Spleens and thymuses 
were removed from the mice after exsanguination; cell suspensions were prepared as described 
by Davie and Paul (3). 
Antigens  and  Iodination.--Human  IgG  (HGG)  was  obtained as  Cohn fraction II  from 
American Red Cross and was further purified by DEAE-cellulose column chromatography; 
ovalbumin (OA) was obtained from Pentex Biochemical, Kankakee, Ill., and bovine serum al- 
bumin  (BSA) was obtained from Armour  & Co., Chicago, Ill. The DNP-HGG, DNP-BSA, 
and DNP-OA were made following the method described by Eisen (23) ; the conjugates had 
55-60, 30-40, and 13-15 tool DNP/mol protein, respectively. The proteins  and  conjugates 
were labeled with 125I (Cambridge Nuclear Co., Cambridge, Mass.) by a chloramine-T pro- 
cedure  (24)  in small volumes  (25).  The DNP-Lys-Tyr  (Cyclo Chemical Co.,  Los Angeles, 
Calif.) was  125I-labeled  by the method of Revoltella et al.  (26).  The specific activity of the 
different preparations varied from 35 to 70 #Ci/#g. 
Antisera.--Antimouse immunoglobulin sera were obtained from rabbits or goats that had 
been injected with either normal mouse IgG or mouse myeloma proteins incorporated into in- 
complete Freund's adjuvant.  The  mouse immunoglobulins were isolated from  the  sera by 
Pevikon electrophoresis followed by Sephadex G-200 exclusion chromatography. Fab and Fc 
fragments were isolated by DEAE-cellulose chromatography after brief digestion with papain 
as previously described  (27). The antisera were made specific for the IgG and IgA Fc frag- 
ments by absorption with Fab fragments and  K-light  chains  (MOPC 46).  Since it was not 
possible to obtain Fab and Fc fragments from mouse IgM, either by papain or trypsin diges- 
tion,  2 the antiserum specific for IgM was prepared by injecting rabbits with/z-chain. The/z- 
chains were isolated from reduced and alkylated IgM by Sephadex G-100 exclusion chroma- 
tography in 1 N acetic acid. The following proteins were used for immunization: normal mouse 
IgG and IgG Fab fragments, K-chain MOPC 46, myeloma proteins S-121  (IgA), and MOPC 
104E (IgM). All antisera were heat inactivated for 30 min at 56°C and absorbed twice with ~/~ 
vol of packed CBA/J erythrocytes. Anti-0 serum was prepared by the method of Reif and 
Allen (28) and shown by cytotoxicity tests to be specific for T lymphocytes. 
A finity-Labeling  Compounds.--The  DNP affinity-labeling compounds used were para-nitro- 
benzenediazonium  fluoborate  (p-NBDF)  and  meta-nitrobenzenediazonium  fluoborate  (m- 
NBDF). "Ihe p-NBDF (Eastman Organic Chemicals Co., Rochester, N.Y.) was recrystallized 
two times from methanol. The m-NBDF was prepared according to the method described by 
Traylor and Singer (29). 
Autoradiographic Assay.--The autoradiographic method employed was a  slight modifica- 
tion of that described by Davie and Paul (3). 20 X  106 lymphoid cells were suspended in 0.2 
ml of minimal essential medium (MEM) which contained 0.1% sodium azide and 10% heat- 
inactivated fetal calf serum  (FCS); 150-200 ng of  125I-labeled  antigen was added. The cell 
smears were  made on microscope slides cleaned with methanol. Autoradiographic exposure 
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time was 7  8 days. The cells were then stained with Giemsa and examined for silver grains. 
Thecriterion used for determining a positive bindingcell was at least 10 grains on or surrounding 
the surface of a  morphologically intact, small lymphocyte; 5000  10,000  ceils per slide were 
counted.  Each experiment was repeated  three or more times with individual spleen or thymus 
cell preparations. 
Inhibition of Antigen-Binding Cells.  Inhibition experiments were performed with unlabeled 
DNP-HGG, DNP-BSA, and HGG by preincubating each with a sample of the lymphoid cell 
suspension for 30 min on ice before the addition of the 12'SI-labeled antigen. For the antisera in- 
hibition studies, cells were preincubated for 2  h  in MEM  with N-2-hydroxyethylpiperazine- 
N'-2-ethanesulfonic acid (HEPES)  buffer (Flow Laboratories, Inglewood, Calif.), which con- 
tained 0.1% sodium azide and 10% heat-inactivated FCS, and the cells were not washed before 
the addition of the 125I-labeled  antigen. A 2 h preincubation in balanced salt solution (BSS) 
followed by a wash was employed, however, for most of the inhibition studies with DNP-Lys, 
p-NBDF, and m-NBDF. In all inhibition experiments, control preparations of each cell pool 
were included and incubated without inhibitors. Each value represents three or more separate 
experiments. 
Treatment of T Cells with Anti-O Antiserum.  Samples of pooled normal thymus cell sus- 
pensions (200 ;< 106 cells) were incubated with heat-inactivated AKR anti-0 serum or normal 
AKR serum,  1:10, for 45 rain at 37°C  and after centrifugation for another 45 rain at 37°C 
with guinea pig serum, 1 : 5, which was previously absorbed with agarose (50 mg/ml) (30) and 
CBA/J erythrocytes in order to remove specific and nonspecific cytotoxicity. After this treat- 
ment, the cells were layered on 100% FCS and the large cell clumps were allowed to settle out. 
The cell suspension was then removed and centrifuged twice through FCS; the final cell pellet 
was resuspended and tested for antigen binding. 
Cortisone Treatment.--Mice were injected intraperitoneally with 2.5 mg of cortisone acetate 
(Merck, Sharp & Dohme, West Point, Pa.) and their thymuses were examined 48 h later (31). 
Cells from thymuses of five mice, which were treated in the above manner, were pooled so that 
20 >(  106 cells could consistently be used for the autoradiographic assay. 
RESULTS 
Antigen-Binding  Cells  in  Normal Mice.--The percentage  of  normal  CBA/J 
spleen  cells  which  bound  DNP-HGG  (0.99%)  was  much  greater  than  that 
binding either the hapten, DNP-Lys-Tyr  (0.09 %), or the carrier, HGG  (0.23 %) 
(Table  I).  The  same  was  true  for  the  percentages  of  the  antigen-binding T 
cells. The percentage of DNP-HGG-binding  cells in the thymuses  (0.15 %) was 
approximately  1/6  of  that  in  the  spleens,  and  there  was  a  greater  degree  of 
variance  in  the percentage  of DNP-HGG-binding  cells  detectable  in  the  thv- 
TABLE  I 
Percentage of Antigen-Binding Lymphoid Calls of Normal CBA/J Mice 
Antigen*  Spleen  Thymus 
DNP57-HGG  0.99  4-  0.16~  0.15  -4-  0.07 
DNP14-OA  0.19  4-  0.07  <0.02 
DNP-Lys-Tyr  0.09  4-  0.03  <0.02 
HGG  0.23  4-  0.04  <0.02 
* Antigens labeled with 1%I. 
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muses (0.08-0.22 %) than was observed in the spleens (0.84-1.2 %). In order to 
study another DNP  conjugate with fewer DNP  residues, DNP-OA  was  em- 
ployed. The number of antigen-binding cells was different when the two DNP 
conjugates,  DNP14-OA  and  DNP57-HGG,  were  compared;  fewer  spleen  cells 
bound  DNP-OA  (0.19%)  than  DNP-HGG  (0.99%),  and  no  thymus  cells 
binding DNP-OA were detected. 
Effect  of Anli-O  Treatment  on  the  ~Vumber of Antigen-Binding  T  Cells.--In 
order to determine if the antigen-binding cells detected in the thymus prepara- 
tions could be immigrant B  cells, the T  cell population in  these preparations 
was reduced by treatment with anti-0 serum and complement before the addi- 
tion of the labeled DNP-HGG. If the binding cells in the thymus preparations 
were  B  cells, this treatment  should have increased the percentage of antigen- 
binding cells. However, as shown in Table II, no  such increase was observed as 
TABLE II 
ESecl  of  Anti-O Serum on  DNP  Binding by  Normal CBA/J  Thymus Cells 
Experiment  Treatment  T cell deatM  Ag-binding  ceils 
%  % 
1"  Normal AKR serum  --  0.12 
AKR anti-0  50  0.12 
2  Normal AKR serum  --  0.22 
AKR anti-0  80  0.13 
3  Normal AKR serum  --  0. ll 
AKR anti-0  68  0.12 
* A sample of 200 X  106 cells from a thymic cell pool were used for treatment with the 
normal and anti-0 sera. 
:~ Determined by cell counts and cell viability assayed by the exclusion of trypan blue. 
compared to treatment of the same thymus cell preparation with normal AKR 
serum and complement. A  50 and 68 %  reduction of T  cells produced no signifi- 
cant  difference in the number  of DNP-HGG-binding cells, and  after an  80% 
reduction  of T  cells, there  was  still no  increase;  in  fact,  the  number  of cells 
binding DNP-HGG  was reduced. 
EffecI of Cortisone  Treatment on the Number of DNP-HGG-Binding  T  Cells.-- 
CBA/J  mice were injected with cortisone before their thymus ceils were har- 
vested in order to determine if the thymic cells which bind DNP-HGG  belong 
to  the  cortisone-sensitive or cortisone-resistant T  cell population.  As can  be 
seen in Table III,  there was no  significant difference in the number  of DNP- 
HGG-binding cells in the thymus cell preparations from normal and cortisone- 
treated mice. As judged by the number of grains seen over the binding cells, it 
was shown,  however,  that  about one-fifth of the cells in the cortisone-treated 474  DNP  RECEPTORS 
populations bound larger  amounts of  DNP-HGG  than  the  T  cells from  the 
normal mice. 
Spec~ficily  of DXP-HGG Binding  by Xormal  Spleen  and  Thymus  Cells.--In 
order to demonstrate the specificity of the DNP-HGG binding by the spleen 
and  thymus cells,  the  inhibitory effects  of  various compounds  were  tested. 
Table IV shows  that  the binding of  DNP-HGG by spleen and  thynms cells 
could be inhibited by the DNP conjugates but not by the carrier protein, HGG, 
even at  a  concentration 100  times that of  the DNP  conjugates. The hapten, 
DNP-Lys, was also used for inhibitory studies. Significant differences between 
the  spleen  and  thymus cell  binding of  DNP-HGG  could  be  detected  when 
DNP-Lys was employed under different conditions. As shown in Table V, DNP- 
Lys significantly inhibited both the  thymus and spleen cell binding of DNP- 
HGG if it was not removed before the addition of the ~I-labeied DNP-HGG. 
TABLE  III 
Effect qf Cortisone Treatment on the Number ~/ DNP-HGG-Binding  Cells in Mice Thymuses 
Positive binding cells/10* cells 
Thymus  cells  .....  Ag binding cells 
<15 grains/cell  >IS grains/'cell 
Normal*  9 
14  --  0.12  =k  0.03+  + 
12 
Cortisone treated§  11  3 
10  3 
8  4 
20  4 
16  5 
0.17  i  0.05 
* Untreated 6-wk-old CBA/J mice. 
$ Standard deviation. 
§ Each group represents a thymic cell pool of five mice which had been treated with 2.5 
mg of cortisone acetate 48 h before thymus removal. 
TABLE  IV 
[nhibitiot~ of [12aI]DNP-HGG Binding in Normal CBA/J Mouse Lymphoid Cells 
Inhibitor*  Concentration  --  -- 
Percent  inhibition 
Spleen  Thymus 
~,g/m! 
DNPaa-BSA  10  80  4-  7:~  >88 
DNP~7-HGG  10  81  -4-  5  >88 
HGG  1,000  0  0 
* 30 rain preincubation with cells and present with labeled antigen. 
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However, if the cells were only preincubated with DNP-Lys, the hapten did not 
significantly inhibit  the binding of the DNP-HGG by the T  cells  (7 %  inhibi- 
tion), whereas 57 %  of the spleen cell binding was still inhibited.  This suggests 
that the T  cells have a lower avidity for the DNP hapten than a portion of the 
cells in the spleen cell preparations. 
The DNP affinity-labeling compounds, m-NBDF and p-NBDF, which have 
been  shown  to  bind  covalently to  the  combining  site  of antibodies  to  DNP 
(32, 33), were used to further study the specificity of the receptors and inhibi- 
tion  of  their  binding  of DNP-HGG.  The  DNP-HGG  binding  by  both  the 
thymus  and  spleen  cells  was  inhibited  equivalently  with  m-NBDF  and  p- 
NBDF. The p-NBDF at 5 X  10  -~ M  concentration was somewhat toxic to the 
"FABLE V 
Inhibitory l~ffect of DNP Haptens on [125I]DNP-HGG Binding by Normal CBA/J 
Lymphoid Cells 
Percent inhibition 
Inhibitor  Concentration 
Spleen  Thymus 
M 
DNP-Lys*  5  X  10  -~  84  :t=  2{  80  =t=  6 
DNP-Lys  5  X  10  -3  57  ~  3  7 -4-  19 
m-NBDF§  5  X  10  -~  81  =k  5  77  =k  5 
5  X  10  -6  64  zk  10  43  ±  12 
p-NBDF[[  5  X  10  -5  87  =k  1  -- 
5  X  10  -6  77  :t= 8  86  =t:  7 
* Lymphoid cells were not washed after prelncubation for 2 h  at 4°C. 
{ Standard deviation. 
§ DNP  affinity labeling compound, meta-nitrobenzenediazonium fluoborate. 
[I DNP affinity labeling compound, para-nitrobenzenediazonium fluoborate. 
T  cells.  At  a  concentration  of 5  X  10  -~  M,  the  p-NBDF  was  slightly more 
inhibitory  on  the  thymus  and  spleen  cell  binding  than  was  the  m-NBDF. 
DNP-Lys, m-NBDF, and p-NBDF had no significant inhibitory effects on the 
binding  of HGG  by spleen  cells  from HGG-immunized  mice.  This  indicates 
that these compounds specifically inhibit DNP receptors. 
Inhibition  of DNP-HGG Binding by Antisera to Immunoglobulin  Chains and 
Fragments.--As  previously  indicated,  the  antigen  receptor  is  believed  to  be 
immunoglobulin-like.  In order to investigate  this possibility in relation  to the 
DNP receptors, antisera specific to immunoglobulin chains and fragments were 
used to inhibit  the binding of DNP-HGG by normal spleen  and thymus cells. 
As seen for the spleen  cells in Table VI, the anti--g-chain serum inhibited  the 
antigen binding by 81%. As a control for specificity, the anti-3,-chain serum was 
absorbed with normal mouse IgG which reduced the inhibition to 12 %, a figure 
similar to that found with normal rabbit serum (21%)  and normal goat serum 476  DNP  RECEPTORS 
(15%).  Of  the  other  sera  specific to  immunoglobulin heavy chains, only the 
anti-/z-chain  serum  was  inhibitory  (55%);  the  anti-a-chain  serum  had  no 
significant inhibitory effect  (15%).  The  anti-Fab and  K-chain sera  were  also 
inhibitory. The inhibitory effect of  the anti-Fab serum  (84%)  was  similar to 
that  of the  anti-3,-chain serum; the  anti-K serum inhibited by 71%.  It is  in- 
teresting to note that both the anti-'y- and/z-chain sera were inhibitory on the 
spleen cell binding of DNP-HGG. The effects of the antisera on the binding of 
DNP-HGG by the normal thymus cells were quite different, as shown in Table 
VII. The anti-/z-chain sera was inhibitory to 74 %; the anti-K and anti-Fab were 
also  significantly inhibitory, 50  and  63%  respectively,  but  the  anti-3'-chain 
sera had no detectable inhibitory effect. 
DISCUSSION 
As shown by the above data, significant percentages of cells that specifically 
bound DNP were detected in the thymuses from normal CBA/J mice. Approxi- 
TABLE  VI 
Inhibitory Effect of Various  A ntisera  on [125I]DNP-HGG Binding by Normal CBA /J 
Mouse Spleen  Cells 
Antiserum  pretreatment*  Percent inhibition 
None  0 
Normal rabbit serum  21  4-  9:~ 
Normal goat serum  15  4-  3 
Rabbit anti-'y-chain§  81  4-  4 
Rabbit anti-3'-chain, abs. "y-chain  12  ±  10 
Goat anti-Fab (IgG)  84  4-  6 
Goat anti-to  71  4-  6 
Rabbit anti-a-chain  15  4-  10 
Rabbit anti-/z-chain  55  4-  23 
* 2 h preincubation at 4°C. 
Standard deviation. 
§ Antisera were heat inactivated  and absorbed with CBA/J erythrocytes. 
TABLE VII 
Inhibitory Effect of Various  Antlsera on [12~I]DNP-IIGG Binding by Normal CBA /J 
Mouse Thymus Cells 
Antiserum  pretreatment*  Percent inhibition 
None 
Rabbit antl-7-chain:  ~ 
Rabbit anti-~z-chaln 
Goat anti-K 
Goat anti-Fab (IgG) 
0 
--5  4-  29§ 
744-5 
50  =~  25 
63  4-  20 
* 2 h prelncubation at 4°C. 
:~ Antisera were heat inactivated and absorbed with CBA/J erythrocytes. 
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mately 1% of a normal spleen cell preparation and 0.15 % of a normal thymus 
ceil preparation bound DNP-HGG. The binding of DNP-HGG by the thymus 
cells varied from animal to animal, but in all,  significant percentages of DNP- 
HGG-binding cells were detectable.  The percentages of antigen-binding  ceils 
are higher  than  most of those previously reported by other investigators for 
other  antigens,  especially  the  percentages  obtained  with  the  thymus  cell 
preparations  (1-3,  13).  Several recent reports of similar high numbers of anti- 
gen-binding  cells  in  thymus  cell  preparations  have been  reviewed by Miller 
et al. (12). The question remains, however, whether or not the thymic antigen- 
binding cells which were detected are truly T  cells.  In the present study, if all 
of  the  DNP-HGG-binding  cells  in  the  thymus  were  immigrant  B  cells,  one 
would have to assume a 15 % contamination of the T  cells with B cells assuming 
that all binding cells in the spleen are B  cells.  This calculation is based on the 
percentages of spleen and thymus cells which were shown to bind DNP-HGG. 
Studies by Roelants  (34)  indicated  that as high as 27% of the normal spleen 
cells that bound Maia sequinado hemocyanin were 0-positive. If this is also true 
to some extent for DNP-HGG-binding cells in the spleen, then the T cell prepa- 
ration would have to contain an even greater number of immigrant B cells. This 
is unlikely,  especially since  the number of B  cells in  the  thymuses of CBA/J 
mice according to Unanue  ~ is less  than 0.3 %. Alternatively,  with such  a  low 
percentage of B cells in CBA/J thymuses, there would have to be approximately 
a 50 times greater proportion of specific DNP-HGG-binding cells in the thymus 
than is observed in the spleen. This is possible, but seems improbable. Further 
evidence that the antigen-binding cells in the thymus are T  cells was obtained 
by analysis of the anti-0-treated thymus cell preparations. If all binders are B 
cells, one would expect an increase after the killing of T  cells. Theoretically, the 
percentage of antigen-binding  B  cells should  have increased 2-,  5-,  and 3-fold 
for the  three  anti-0  experiments,  respectively (Table II); however,  there was 
no increase in  the number of DNP-HGG-binding cells.  A  2-fold reduction  of 
antigen-binding T  cells was found after killing 80% of T  cells,  which suggests 
that the antigen-binding T  cells vary in their sensitivities to anti-0 serum and 
agrees with the work of Raft and Cantor (35)  who stated that there are sub- 
populations of T  cells differing in their sensitivities to anti-0 serum. 
The higher percentage of cells binding DNP-HGG than other antigens may 
have been detected because ot a higher avidity of this conjugate to the lympho'.d 
ce;ls.  The reason for this could be that one DNP-HGG molecule can bind to 
more than one receptor per cell because of the size of the DNP-HGG conjugate, 
the  number  of  DNP  residues,  and  other  possible  specific  characteristics  of 
DNP-HGG.  The  differences  in  binding  avidities  and  the  specific  ability  of 
DNP-HGG to bind particularly well  are substantiated by the fact that many 
more sp'.een and thymus cells bound DNPaT-HGG than DNP14-OA. Differences 
3 Unanue, E. R. Petsonai communication. 478  DNP  RECEPTORS 
in binding avidity of various DNP conjugates have also been demonstrated by 
Davie and  Paul  (36).  These  authors  have shown  that  carrier molecules with 
more DNP residues have a greater avidity for the antigen-binding cells and that 
the size of the carrier molecule also influences binding avidity. The high num- 
bers of DNP-HGG-binding cells probably also reflect the fact that DNP is a 
highly immunogenic, haptenic determinant as has been observed by other in- 
vestigators (21,  22). 
The T  cells which bound the DNP-HGG were equally proportioned between 
the T cell subpopulations of cortisone-sensitive and cortisone-resistant cells. The 
cortisone  treatment  consistentlv  reduced  the  T  cell  population  by  approxi- 
mately 95 % ; the percentage of antigen-binding cells in the remaining thymus 
did not  significantly change. After this treatment  there was, however, a small 
number of cells which bound  an unusually large amount of DNP-HGG (> 15 
grains/cell). Since the maximum number of such cells that were ever observed in 
the thymus preparations was 1/104  cells,  these particular cells do not seem to 
be normal  constituents  of the  thymus.  They may be B  cells which  are more 
easily detected  after the extensive reduction of the T  cells,  or they may be B 
cells which have immigrated into the thymus after the cortisone treatment since 
the majority of the positive binding cells in the spleen have more than 15 grains,/ 
cell. The failure to find a significant difference in the antigen-binding capabilities 
of the cortisone-sensitive (cortical T  cells)  and cortisone-resistant thymus cells 
(medullary  T  cells)  suggests  that  the  maturation  process  of  the  immuno- 
competent T  cell  is initiated in the cortex. The theory that T  cells gain their 
immunological  competence within  the medullary part of the  thymus (37,  38) 
is based on reports (31,  39)  which measure T  cell functions other than antigen 
binding. Our results which do not indicate any significant increase in the number 
of antigen-binding  T  cells  after the  cortisone  treatment  do  conflict with  the 
results of Bach and Dardenne (10)  and Miller et al. (12) who have shown a sig- 
nificant increase of binding cells after the treatment. It should be noted,  how- 
ever, that different techniques were employed, and therefore the sensitivities of 
the assays and the populations of cells being detected may have differed. 
The binding of DNP-HGG by the thymus and spleen cells was shown to be 
specific to DNP by inhibition studies. The DNP conjugates had an inhibitory 
effect, whereas the HGG alone could not inhibit the DNP-HGG binding. The 
hapten  DNP-Lys  and  the  affinity-labeling  reagents  m-NBDF  and  p-NBDF 
also  specifically inhibited  the  binding  of DNP-HGG.  If the  affinity-labeling 
compounds m-NBDF and p-NBDF, which are shown here to bind specifically 
to DNP receptors, presumably bind covalently to the antigen-combining site of 
the  receptors as they do  with  the  anti-DNP  immunoglobulins  (32,  33),  they 
may serve as useful tools in future studies for the isolation of the DNP receptor. 
The  DNP-HGG  antigen-binding  cells  of  the  thvnms  appeared  to  have  a 
lower avidity than the antigen-binding spleen cells.  This apparent low  avidity 
of the T  cells to antigen could account for the past inabilitv of investigators to LAWRENCE,  SPIEGELBERG,  AND  WEIGLE  479 
readily detect T  cells  binding  other  antigens.  Recently,  Haskill  et  al.  (40) 
reported that T  cells have low antigen-binding properties and that the bound 
antigen easily dissociates from the cellular receptors if a  fixative is not used; 
this  agrees  with  our data  which  indicate  that  T  cells have  low  avidity for 
antigens. The low avidity of the T  cell could be due to fewer receptors per cell 
compared with  the number of receptors on  the B  cells and/or lower intrinsic~ 
affinity of the individual receptors. It should be emphasized that this compari- 
son is in terms of average avidities (41); possibly some T  cells have an avidity 
for DNP-HGG equal to or greater than some of the cells in the spleen. 
The DNP  receptors on a  large proportion of the spleen cells  from CBA/J 
mice have ~'-heavy chains,  and the DNP  receptors on the thymus cells were 
mainly /z-chains.  No  significant  differences between  the  thymic  and  splenic 
receptors were detected with anti-~ or anti-Fab sera. Since the DNP receptors on 
the thymus cells  were shown to be mainly/z-chain immunoglobulins and the 
receptors seemed to have a low avidity for antigen, the cells in the thymus may 
be  in  a  primary  and  immunologically  undeveloped  state.  The  spleen  cells 
mainly  have  ~,-chain  receptors  to  DNP  possibly  because  of previous  DNP 
stimulation even in the "normal" mice and thus are in a secondary response. 
The 55 % of the spleen cell  population which is inhibited by the anti-#-chain 
serum may represent T  cells in the spleen. The presence of/z-chains on thymus 
cells has also been reported by other investigators. The surface immunoglobulins 
isolated from murine thymus cells have been IgM immunoglobulins (42), and 
Dwyer et al. (13) have shown that the binding of antigen by fetal thymic cells 
of mice and man is inhibited by anti-/z-chain serum. Different findings on the 
predominant class of immunoglobulins present on all of the immunoglobulin- 
positive lymphocytes have been reported; some investigators indicate that the 
majority of  these  cells  in  mice have ~/-chain  surface immunoglobulins  (14), 
others indicate/z-chains (43), and still  others have reported that all immuno- 
globulin classes are present on the surface of each mouse lymphocyte (44). In 
the present  investigation,  the  majority of DNP  antigen-binding  spleen  cells 
appear  to  have "y-chain  receptors.  Davie  and  Paul  (3)  have  shown  that  in 
normal guinea pigs the majority of the DNP receptors are also IgG2 immuno- 
globulins. The anti-immunoglobulin studies are an indirect way to investigate 
the nature of cell receptors; positive identification of the receptors on T  and B 
cells will rest on their isolation and complete characterization. 
SUMMARY 
A  higher percentage of specific antigen-binding  cells  can  be  detected not 
only in normal CBA/J mouse spleen cell preparations (0.99%), but also in the 
normal thymus cell preparations (0.15 %) with the use of [~25I]2,4-dinitrophenyl- 
human  IgG  (DNP-HGG)  as  compared with  most  other antigens  employed 
under similar conditions. The receptors on these cells are mainly specific for 
the DNP group as shown by the inhibition studies with DNP-lysine and the ~80  DNP  RECEPTORS 
other DNP conjugates. In addition, it was shown by the inhibition studies with 
I)NP-lvsine that the thymus cells seem to have a  lower avidity for DNP  than 
the  spleen  cells.  Preincubation  of  cell  suspensions  with  antisera  to  immuno- 
globulins showed that the DNP-HGG  antigen-binding cells in the thymus are 
inhibited  predominantly  with  anti->-chain  serum  and  the  spleen  cells  with 
both anti-#-chain and anti-3,-chain sera; both cell populations were also signifi- 
cantly inhibited with the antisera to a-chains and Fab fragments. These data 
indicate that  the nature of the receptor on the T  cell differs from that on the 
majority, of spleen cells. 
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